Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy.

Abstract

BACKGROUND The aim of neoadjuvant chemotherapy is to increase the likelihood of successful breast conservation surgery (BCS). Accurate identification of BCS candidates is a diagnostic challenge. Breast Cancer Index (BCI) predicts recurrence risk in estrogen receptor+lymph node-breast cancer. Performance of BCI to predict chemosensitivity based on… (More)
DOI: 10.1093/annonc/mdr550

Topics

5 Figures and Tables

Cite this paper

@article{Mathieu2012BreastCI, title={Breast Cancer Index predicts pathological complete response and eligibility for breast conserving surgery in breast cancer patients treated with neoadjuvant chemotherapy.}, author={Marie Christine Mathieu and Chafika Mazouni and Nicole C. Kesty and Y Zhang and V{\'e}ronique Scott and J. P. Passeron and Monica Arnedos and Catherine A. Schnabel and Suzette Delaloge and Mark G. Erlander and Fabrice Andre}, journal={Annals of oncology : official journal of the European Society for Medical Oncology}, year={2012}, volume={23 8}, pages={2046-52} }